dinitrochlorobenzene has been researched along with Metastase in 43 studies
Dinitrochlorobenzene: A skin irritant that may cause dermatitis of both primary and allergic types. Contact sensitization with DNCB has been used as a measure of cellular immunity. DNCB is also used as a reagent for the detection and determination of pyridine compounds.
1-chloro-2,4-dinitrobenzene : A C-nitro compound that is chlorobenzene carrying a nitro substituent at each of the 2- and 4-positions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Eighteen patients with multiple recurrences of malignant melanoma without evident distant spread were randomly assigned to treatment with either intralesional Bacillus Calmette-Guerin (BCG) or intralesional dinitrochlorobenzene (DNCB)." | 9.04 | Intralesional treatment of recurrent metastatic cutaneous malignant melanoma: a randomized prospective study of intralesional Bacillus Calmette-Guerin versus intralesional dinitrochlorobenzene. ( Cohen, MH; Felix, EL; Herberman, RB; Jessup, JM; Weese, JL, 1978) |
| "To scrutinize published data from small mono-centric studies and case reports which implicated high response rates and promising survival times for a combination therapy consisting of epifocal dinitrochlorobenzene (DNCB) and dacarbazine (DTIC) for metastasized melanoma." | 7.74 | Chemoimmunotherapy for cutaneous melanoma with dacarbazine and epifocal contact sensitizers: results of a nationwide survey of the German Dermatologic Co-operative Oncology Group. ( Becker, JC; Beiteke, U; Bröcker, EB; Durani, B; Jünger, M; Junghans, V; Kortüm, AK; Mauch, C; Remling, R; Schadendorf, D; Schulze, HJ; Terheyden, P, 2007) |
| "An empirically established chemoimmunotherapy for metastatic melanoma combines the systemic administration of the chemotherapeutic agent dacarbazine (DTIC) with the epifocal application of the contact sensitizer 2,4-dinitrochlorobenzene (DNCB) on cutaneous metastases." | 7.71 | Chemoimmunotherapy for melanoma with dacarbazine and 2,4-dinitrochlorobenzene elicits a specific T cell-dependent immune response. ( Becker, JC; Bröcker, EB; Fischer, WH; Kirst, A; Lutz, WK; Wack, C, 2002) |
| "35 patients with malignant melanomas in different stages were treated with dinitrochlorobenzene according to Malek-Mansour in the last three years." | 7.66 | [Treatment of malignant melanoma with dinitrochlorobenzene ointment]. ( Ehring, F; Loth, H, 1978) |
| "This set of experiments was devised to determine the effects of the commonly employed anesthetic induction agent, thiopental, on the incidence of pulmonary metastases in a murine fibrosarcoma system." | 7.65 | Pulmonary metastases, a potential biologic consequence of anesthetic-induced immunosuppression by thiopental. ( Conran, P; Lovett, EJ; Lundy, J, 1977) |
| "Subcutaneous (s." | 5.31 | Chemoimmunotherapy for melanoma with dacarbazine and 2,4-dinitrochlorobenzene elicits a specific T cell-dependent immune response. ( Becker, JC; Bröcker, EB; Fischer, WH; Kirst, A; Lutz, WK; Wack, C, 2002) |
| "This was correlated with an impaired delayed hypersensitivity reaction to the de novo antigen." | 5.26 | Pulmonary metastases, a potential biologic consequence of anesthetic-induced immunosuppression by thiopental. ( Conran, P; Lovett, EJ; Lundy, J, 1977) |
| "Distant metastases may react--but normally these metastases cannot be removed." | 5.26 | [Treatment of malignant melanoma with dinitrochlorobenzene ointment]. ( Ehring, F; Loth, H, 1978) |
| "Eighteen patients with multiple recurrences of malignant melanoma without evident distant spread were randomly assigned to treatment with either intralesional Bacillus Calmette-Guerin (BCG) or intralesional dinitrochlorobenzene (DNCB)." | 5.04 | Intralesional treatment of recurrent metastatic cutaneous malignant melanoma: a randomized prospective study of intralesional Bacillus Calmette-Guerin versus intralesional dinitrochlorobenzene. ( Cohen, MH; Felix, EL; Herberman, RB; Jessup, JM; Weese, JL, 1978) |
| "To scrutinize published data from small mono-centric studies and case reports which implicated high response rates and promising survival times for a combination therapy consisting of epifocal dinitrochlorobenzene (DNCB) and dacarbazine (DTIC) for metastasized melanoma." | 3.74 | Chemoimmunotherapy for cutaneous melanoma with dacarbazine and epifocal contact sensitizers: results of a nationwide survey of the German Dermatologic Co-operative Oncology Group. ( Becker, JC; Beiteke, U; Bröcker, EB; Durani, B; Jünger, M; Junghans, V; Kortüm, AK; Mauch, C; Remling, R; Schadendorf, D; Schulze, HJ; Terheyden, P, 2007) |
| "An empirically established chemoimmunotherapy for metastatic melanoma combines the systemic administration of the chemotherapeutic agent dacarbazine (DTIC) with the epifocal application of the contact sensitizer 2,4-dinitrochlorobenzene (DNCB) on cutaneous metastases." | 3.71 | Chemoimmunotherapy for melanoma with dacarbazine and 2,4-dinitrochlorobenzene elicits a specific T cell-dependent immune response. ( Becker, JC; Bröcker, EB; Fischer, WH; Kirst, A; Lutz, WK; Wack, C, 2002) |
| "An empirically established chemoimmunotherapy that combines the epifocal application of the contact sensitizer dinitrochlorobenzene (DNCB) to cutaneous metastases with the systemic administration of dacarbazine (DTIC) yields high response rates and results in prolonged survival." | 3.71 | Chemoimmunotherapy for melanoma with dacarbazine and 2,4-dinitrochlorobenzene: results from a murine tumour model. ( Becker, JC; Bröcker, EB; Fischer, WH; Lutz, WK; Wack, C, 2001) |
| "The nonspecific cell-mediated immunocompetence of 51 patients with gestational trophoblastic disease (GTD), including 16 patients with hydatid mole (HM), 24 with nonmetastatic trophoblastic neoplasia (NTN) and 15 with metastatic TN (MTN), was studied with the use of both in vitro and in vivo parameters of cell-mediated immunity (CMI) such as lymphocyte blastogenic response to phytohemagglutinin (PHA), subpopulation constitution, and delayed cutaneous hypersensitivity responses to 2,4-dinitrochlorobenzene (DNCB) and to purified protein derivative of tuberculin (PPD)." | 3.66 | Clinical studies on cell-mediated immunity in gestational trophoblastic disease: nonspecific cellular immunocompetence in patients with hydatid mole and trophoblastic neoplasia. ( Fujisaki, S; Sasaki, T, 1981) |
| "Delayed cutaneous hypersensitivity to 2,3-dinitrochlorobenzene (DNCB) was tested in 419 patients with malignant melanoma to determine whether DNCB reactivity was associated with prognosis." | 3.66 | DNCB reactivity and prognosis in 419 patients with malignant melanoma. ( Braun, DW; Camacho, ES; Fortner, JG; Golbey, RB; Oettgen, HF; Pinsky, CM; Wanebo, HJ, 1981) |
| "35 patients with malignant melanomas in different stages were treated with dinitrochlorobenzene according to Malek-Mansour in the last three years." | 3.66 | [Treatment of malignant melanoma with dinitrochlorobenzene ointment]. ( Ehring, F; Loth, H, 1978) |
| "Report on the application of a dinitrochlorobenzene ointment of 61 postoperative melanoma patients exhibiting clinical stages I and II." | 3.66 | [Adjuvant DNCB immunotherapy in malignant melanoma]. ( Djawari, D; Weidner, F, 1979) |
| "Cell factors of nonspecific immunity were estimated in 99 patients with different stages of melanoblastoma by delayed hypersensitivity skin test to tuberculin and DNCB (2,4-dinitrochlorobenzene)." | 3.66 | [Skin reactions of delayed hypersensitivity in melanoblastoma]. ( Khachaturian, LM; Korosteleva, TA; Potapenkova, LS; Ryzhkov, VI, 1979) |
| "This set of experiments was devised to determine the effects of the commonly employed anesthetic induction agent, thiopental, on the incidence of pulmonary metastases in a murine fibrosarcoma system." | 3.65 | Pulmonary metastases, a potential biologic consequence of anesthetic-induced immunosuppression by thiopental. ( Conran, P; Lovett, EJ; Lundy, J, 1977) |
| "Spontaneous remission of pulmonary metastases from renal cell carcinoma was correlated with a positive response to dinitrochlorobenzene (DNCB)." | 3.65 | Immunocompetence and spontaneous regression of metastatic renal cell carcinoma. ( Boasberg, PD; Eilber, FR; Morton, DL, 1976) |
| " Delayed hypersensitivity was tested by dinitrochlorobenzene skin tests and responses to phytohemagglutinin." | 3.65 | Adrenalectomy and oophorectomy plus limited-term chemotherapy in the treatment of breast cancer. ( Asal, NR; Bottomley, RH; Hoge, AF; Shaw, MT, 1976) |
| "Cell-mediated immunocompetence of patients seen for followup of adenocarcinoma of the prostate is evaluated using dinitrochlorobenzene as a contact sensitizing agent." | 3.65 | Delayed cutaneous hypersensitivity in patients with prostatic adenocarcinoma. ( Huus, JC; Kursh, ED; Persky, L; Poor, P, 1975) |
| "Subcutaneous (s." | 1.31 | Chemoimmunotherapy for melanoma with dacarbazine and 2,4-dinitrochlorobenzene elicits a specific T cell-dependent immune response. ( Becker, JC; Bröcker, EB; Fischer, WH; Kirst, A; Lutz, WK; Wack, C, 2002) |
| "Patients with metastases showed a significantly decreased response to DNCB compared to the results obtained before radiotherapy." | 1.27 | [The immune status of patients with irradiated testicular neoplasms]. ( Csere, T; Kuhn, E; Stefanits, K, 1985) |
| "This was correlated with an impaired delayed hypersensitivity reaction to the de novo antigen." | 1.26 | Pulmonary metastases, a potential biologic consequence of anesthetic-induced immunosuppression by thiopental. ( Conran, P; Lovett, EJ; Lundy, J, 1977) |
| "3 melanoma patients suffering from skin metastases were treated by epifocal DNCB-application." | 1.26 | [Adjuvant DNCB immunotherapy in malignant melanoma]. ( Djawari, D; Weidner, F, 1979) |
| "However, central nervous system (CNS) metastases continue to develop in these patients and represent the single most frequent cause of death." | 1.26 | Failure of adjuvant immunotherapy to prevent central nervous system metastases in malignant melanoma patients. ( Eilber, FR; Grooms, GA; Morton, DL, 1977) |
| "Anergy demonstrated by delayed hypersensitivity skin testing appears to reflect increasing tumor burden, rather than a preexisting deficiency that can be used to predict patients at high risk for the development of recurrent disease." | 1.26 | Malignant melanoma. Delayed hypersensitivity skin testing. ( Campion, JF; Gumport, SL; Harris, MN; Roses, DF, 1979) |
| "Three mo later, the patient developed brain metastases although X-ray examination showed no pulmonary nodules." | 1.26 | Immunocompetence and spontaneous regression of metastatic renal cell carcinoma. ( Boasberg, PD; Eilber, FR; Morton, DL, 1976) |
| "Spontaneous remission of pulmonary metastases from renal cell carcinoma was correlated with a positive response to dinitrochlorobenzene (DNCB)." | 1.26 | Immunocompetence and spontaneous regression of metastatic renal cell carcinoma. ( Boasberg, PD; Eilber, FR; Morton, DL, 1976) |
| "Delayed hypersensitivity was tested by dinitrochlorobenzene skin tests and responses to phytohemagglutinin." | 1.26 | Adrenalectomy and oophorectomy plus limited-term chemotherapy in the treatment of breast cancer. ( Asal, NR; Bottomley, RH; Hoge, AF; Shaw, MT, 1976) |
| "Distant metastases may react--but normally these metastases cannot be removed." | 1.26 | [Treatment of malignant melanoma with dinitrochlorobenzene ointment]. ( Ehring, F; Loth, H, 1978) |
| "Thiabendazole (TBZ) appears to be an immunorestorative agent, demonstrating maximum immunopotentiation in the immunosuppressed host." | 1.26 | Immunomodulation with thiabendazole: a review of immunologic properties and efficacy in combined modality cancer therapy. ( Lovett, EJ; Lundy, J, 1978) |
| "The DNCB-method in malignant melanoma is yet in the experimental stage and is not recommended for general use in practice." | 1.26 | [Adjuvant DNCB immunotherapy in malignant melanoma]. ( Djawari, D; Weidner, F, 1979) |
| "Immunotherapy against cancer in animals has been established." | 1.25 | Immunotherapy of malignancy in humans. Current status. ( Eilber, FR; Holmes, EC; Morton, DL, 1975) |
| "Croton oil was used to evaluate the non-specific inflammatory response." | 1.25 | Studies on the immune status of patients with renal adenocarcinoma. ( Brosman, S; Hausman, M; Shacks, SJ, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 39 (90.70) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (9.30) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wack, C | 2 |
| Kirst, A | 1 |
| Becker, JC | 3 |
| Lutz, WK | 2 |
| Bröcker, EB | 3 |
| Fischer, WH | 2 |
| Herrmann, G | 1 |
| Groth, W | 1 |
| Krieg, T | 1 |
| Mauch, C | 2 |
| Terheyden, P | 1 |
| Kortüm, AK | 1 |
| Schulze, HJ | 1 |
| Durani, B | 1 |
| Remling, R | 1 |
| Junghans, V | 1 |
| Schadendorf, D | 1 |
| Beiteke, U | 1 |
| Jünger, M | 1 |
| Cron, J | 1 |
| Jansa, P | 1 |
| Sasaki, T | 1 |
| Fujisaki, S | 1 |
| Heid, E | 1 |
| Grosshans, E | 1 |
| Laplanche, G | 1 |
| Caussade, P | 1 |
| Camacho, ES | 1 |
| Pinsky, CM | 3 |
| Braun, DW | 2 |
| Golbey, RB | 1 |
| Fortner, JG | 1 |
| Wanebo, HJ | 2 |
| Oettgen, HF | 2 |
| Adler, A | 1 |
| Stein, JA | 1 |
| Ben-Efraim, S | 1 |
| Krown, SE | 1 |
| Wong, PP | 1 |
| Taylor, MA | 1 |
| Israel, BA | 1 |
| Escobar, MR | 1 |
| Berlinerman, D | 1 |
| Lundy, J | 2 |
| Lovett, EJ | 2 |
| Conran, P | 1 |
| Holmes, EC | 1 |
| Eilber, FR | 3 |
| Morton, DL | 4 |
| Grooms, GA | 1 |
| Brosman, S | 3 |
| Elhilali, M | 1 |
| Vescera, C | 1 |
| Fahey, J | 1 |
| Ryzhkov, VI | 1 |
| Potapenkova, LS | 1 |
| Korosteleva, TA | 1 |
| Khachaturian, LM | 1 |
| Webster, DJ | 1 |
| Richardson, G | 1 |
| Baum, M | 1 |
| Priestman, T | 1 |
| Hughes, LE | 1 |
| Weidner, F | 1 |
| Djawari, D | 1 |
| DeMeester, TR | 1 |
| Golomb, HM | 1 |
| Dudek, P | 1 |
| Hunter, RL | 1 |
| Fang, VS | 1 |
| Loth, H | 1 |
| Ehring, F | 1 |
| Cohen, MH | 2 |
| Jessup, JM | 1 |
| Felix, EL | 1 |
| Weese, JL | 1 |
| Herberman, RB | 1 |
| Stefani, SS | 1 |
| Menon, M | 1 |
| Canning, JR | 1 |
| Clark, SS | 1 |
| Roses, DF | 1 |
| Campion, JF | 1 |
| Harris, MN | 1 |
| Gumport, SL | 1 |
| Tritsch, H | 1 |
| Rangel, DM | 1 |
| Golub, SH | 1 |
| Wätzig, V | 1 |
| Boasberg, PD | 1 |
| Shcherban', EI | 1 |
| Strashinina, OA | 1 |
| Vladimirova, VA | 1 |
| Ivanova, LV | 1 |
| Libson, IL | 1 |
| Hoge, AF | 1 |
| Bottomley, RH | 1 |
| Shaw, MT | 1 |
| Asal, NR | 1 |
| Illig, L | 1 |
| Paul, E | 1 |
| Wanebo, H | 1 |
| Mike, V | 1 |
| Oettgen, H | 1 |
| Bolton, PM | 1 |
| Huus, JC | 1 |
| Kursh, ED | 1 |
| Poor, P | 1 |
| Persky, L | 1 |
| Hausman, M | 2 |
| Shacks, SJ | 1 |
| Shacks, S | 1 |
| Bulkley, GB | 1 |
| Banks, PM | 1 |
| Char, DH | 1 |
| Ketcham, AS | 1 |
| Pauwels, R | 1 |
| van der Straeten, M | 1 |
| Parker, R | 1 |
| Alexander, S | 1 |
| Shaheen, OH | 1 |
| Parkes, P | 1 |
| Catalona, WJ | 1 |
| Smolev, JK | 1 |
| Harty, JI | 1 |
| Cunningham, TJ | 1 |
| Daut, D | 1 |
| Wolfgang, PE | 1 |
| Mellyn, M | 1 |
| Maciolek, S | 1 |
| Sponzo, RW | 1 |
| Horton, J | 1 |
| Remy, W | 1 |
| Dorn, R | 1 |
| Ulm, K | 1 |
| Mayerhausen, W | 1 |
| Stefanits, K | 1 |
| Kuhn, E | 1 |
| Csere, T | 1 |
3 reviews available for dinitrochlorobenzene and Metastase
| Article | Year |
|---|---|
[Dinitrochlorobenzene. Therapeutic use].
Topics: Alopecia Areata; Carcinoma, Basal Cell; Dermatitis, Contact; Dinitrochlorobenzene; Humans; Hypersens | 1984 |
[Development in the immunotherapy of malignant melanoma].
Topics: Adjuvants, Immunologic; Antibodies, Neoplasm; Antigens, Neoplasm; BCG Vaccine; Cytotoxicity Tests, I | 1976 |
DNCB sensitivity in cancer patients. A review based on sequential testing in 430 patients.
Topics: Adenocarcinoma; Adult; Breast Neoplasms; Carcinoma, Squamous Cell; Colonic Neoplasms; Dinitrochlorob | 1975 |
2 trials available for dinitrochlorobenzene and Metastase
| Article | Year |
|---|---|
Effect of treatment on the immunological status of women with advanced breast cancer.
Topics: Antibody Formation; Antigens; Antineoplastic Agents; Breast Neoplasms; Dinitrochlorobenzene; Female; | 1979 |
Intralesional treatment of recurrent metastatic cutaneous malignant melanoma: a randomized prospective study of intralesional Bacillus Calmette-Guerin versus intralesional dinitrochlorobenzene.
Topics: Adult; Aged; Antigens; Antigens, Neoplasm; BCG Vaccine; Cell Migration Inhibition; Dinitrochlorobenz | 1978 |
38 other studies available for dinitrochlorobenzene and Metastase
| Article | Year |
|---|---|
Chemoimmunotherapy for melanoma with dacarbazine and 2,4-dinitrochlorobenzene elicits a specific T cell-dependent immune response.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Combined Modality Therapy; Dacarb | 2002 |
Complete remission of Merkel cell carcinoma of the scalp with local and regional metastases after topical treatment with dinitrochlorbenzol.
Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Carcinoma, Merkel Cell; Dinitrochlorobenzene; | 2004 |
Chemoimmunotherapy for cutaneous melanoma with dacarbazine and epifocal contact sensitizers: results of a nationwide survey of the German Dermatologic Co-operative Oncology Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Dinitrochlorobenzene; Dise | 2007 |
Role of phagocytic cells in cancer.
Topics: Anaerobiosis; Antineoplastic Agents; Breast Neoplasms; Complement Activation; Dinitrochlorobenzene; | 1981 |
Clinical studies on cell-mediated immunity in gestational trophoblastic disease: nonspecific cellular immunocompetence in patients with hydatid mole and trophoblastic neoplasia.
Topics: Adult; Azides; B-Lymphocytes; Dinitrochlorobenzene; DNA; Drug Hypersensitivity; Female; Humans; Hyda | 1981 |
DNCB reactivity and prognosis in 419 patients with malignant melanoma.
Topics: Dinitrochlorobenzene; Humans; Hypersensitivity, Delayed; Melanoma; Neoplasm Metastasis; Neoplasm Rec | 1981 |
Immunocompetence, immunosuppression, and human breast cancer. II. Further evidence of initial immune impairment by integrated assessment effect of nodal involvement (N) and of primary tumor size (T).
Topics: Adult; Aged; Breast Neoplasms; Dinitrochlorobenzene; Female; Humans; Immunity, Cellular; Immunizatio | 1980 |
Immunologic reactivity and prognosis in breast cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Dinitrochlorobenzene; Female; | 1980 |
Chemoimmunotherapy for melanoma with dacarbazine and 2,4-dinitrochlorobenzene: results from a murine tumour model.
Topics: Animals; Antineoplastic Agents, Alkylating; Combined Modality Therapy; Dacarbazine; Dinitrochloroben | 2001 |
In vitro and in vivo parameters of humoral and cellular immunity in an animal model for protein-calorie malnutrition.
Topics: Animals; Antibody Formation; Blood Proteins; Cell Transformation, Neoplastic; Complement System Prot | 1979 |
Pulmonary metastases, a potential biologic consequence of anesthetic-induced immunosuppression by thiopental.
Topics: Anesthetics; Animals; Dinitrochlorobenzene; Fibrosarcoma; Hypersensitivity, Delayed; Immunosuppressi | 1977 |
Immunomodulation with thiabendazole: a review of immunologic properties and efficacy in combined modality cancer therapy.
Topics: Animals; Cyclophosphamide; Dinitrochlorobenzene; Drug Therapy, Combination; Humans; Hypersensitivity | 1978 |
Immunotherapy of malignancy in humans. Current status.
Topics: Adjuvants, Immunologic; Antigens, Neoplasm; BCG Vaccine; Carcinoma, Basal Cell; Carcinoma, Squamous | 1975 |
Failure of adjuvant immunotherapy to prevent central nervous system metastases in malignant melanoma patients.
Topics: Adjuvants, Immunologic; BCG Vaccine; Brain Neoplasms; Dinitrochlorobenzene; Humans; Immunotherapy; L | 1977 |
Immune response in bladder cancer patients.
Topics: Adult; Aged; Antibody-Dependent Cell Cytotoxicity; Croton Oil; Cytotoxicity Tests, Immunologic; Dini | 1979 |
[Skin reactions of delayed hypersensitivity in melanoblastoma].
Topics: Adult; Aged; Dinitrochlorobenzene; Humans; Hypersensitivity, Delayed; Immunity, Cellular; Immunity, | 1979 |
[Adjuvant DNCB immunotherapy in malignant melanoma].
Topics: Adult; Aged; Dinitrochlorobenzene; Female; Humans; Male; Melanoma; Melphalan; Middle Aged; Neoplasm | 1979 |
The relationship between immune reactivity, serum cortisol, and stage of disease in patients with non-oat-cell bronchogenic carcinoma.
Topics: Carcinoma, Bronchogenic; Circadian Rhythm; Dinitrochlorobenzene; Humans; Hydrocortisone; Immunity, C | 1979 |
[Treatment of malignant melanoma with dinitrochlorobenzene ointment].
Topics: Aged; Dinitrochlorobenzene; Female; Humans; Melanoma; Middle Aged; Neoplasm Metastasis; Nitrobenzene | 1978 |
Cell-mediated immune competence in patients with prostatic carcinoma.
Topics: Carcinoma; Dinitrochlorobenzene; Humans; Hypersensitivity, Delayed; Immunity, Cellular; Leukocyte Co | 1978 |
Malignant melanoma. Delayed hypersensitivity skin testing.
Topics: Adult; Aged; Antigens; Dinitrochlorobenzene; Female; Follow-Up Studies; Humans; Hypersensitivity, De | 1979 |
Demonstration of lymphocyte blastogenesis--inhibiting factors in sera of melanoma patients.
Topics: Adolescent; Adult; Aged; Dinitrochlorobenzene; Female; Humans; In Vitro Techniques; Lymphocyte Activ | 1977 |
[DNCB immunotherapy for removal of melanoma skin metastases].
Topics: Dinitrochlorobenzene; Humans; Immunotherapy; Melanoma; Neoplasm Metastasis; Nitrobenzenes; Skin Neop | 1977 |
Immunocompetence and spontaneous regression of metastatic renal cell carcinoma.
Topics: Adenocarcinoma; Brain Neoplasms; Dinitrochlorobenzene; Humans; Kidney Neoplasms; Lung Neoplasms; Mal | 1976 |
[Immunologic state of patients with cancer of the lung, pharynx, larynx, thyroid gland, treated with radiation].
Topics: Dinitrochlorobenzene; Humans; Laryngeal Neoplasms; Lung Neoplasms; Neoplasm Metastasis; Nitrobenzene | 1976 |
Adrenalectomy and oophorectomy plus limited-term chemotherapy in the treatment of breast cancer.
Topics: Adrenalectomy; Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Castration; Dinitrochlorobenzen | 1976 |
[The nonspecific epifocal Malek-Mansour immunotherapy of malignant cutaneous melanoma using DNCB].
Topics: Administration, Topical; Adult; Aged; Cell Transformation, Neoplastic; Dinitrochlorobenzene; Female; | 1976 |
Delayed cutaneous hypersensitivity reactions and prognosis in patients with cancer.
Topics: Dinitrochlorobenzene; Humans; Hypersensitivity, Delayed; Neoplasm Metastasis; Neoplasm Recurrence, L | 1976 |
Delayed cutaneous hypersensitivity in patients with prostatic adenocarcinoma.
Topics: Adenocarcinoma; Aged; Dinitrochlorobenzene; Follow-Up Studies; Humans; Hypersensitivity, Delayed; Im | 1975 |
Studies on the immune status of patients with renal adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antigens; Chemotaxis; Croton Oil; Dinitrochlorobenzene; Female; Humans; | 1975 |
Immunologic alterations in patients with prostatic carcinoma.
Topics: Adult; Aged; Antigen-Antibody Reactions; Chemotaxis; Croton Oil; Dinitrochlorobenzene; Humans; Hyper | 1975 |
Long-term spontaneous regression of malignant melanoma with visceral metastases. Report of a case with immunologic profile.
Topics: Autoantigens; Cell Migration Inhibition; Cytotoxicity Tests, Immunologic; Dinitrochlorobenzene; Fema | 1975 |
Delayed hypersensitivity in patients with bronchial carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Bronchial Neoplasms; Carcinoma; Carcinoma, Squamous Cell; Dinitrochloro | 1975 |
On the immunology of head and neck cancer--a prognostic index. Preliminary communication.
Topics: Antibody Formation; Dinitrochlorobenzene; Female; Head and Neck Neoplasms; Humans; Lymphocyte Activa | 1975 |
Prognostic value of host immunocompetence in urologic cancer patients.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Transitional Cell; Dinitrochlorobenzene; Female; Follow-Up S | 1975 |
A correlation of DNCB-induced delayed cutaneous hypersensitivity reactions and the course of disease in patients with recurrent breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Dinitrochlorobenzene; Female; Humans; Hypersen | 1976 |
[Decrease in immunoreactivity in melanoma. Analysis of DNCB tests in the literature].
Topics: Dinitrochlorobenzene; Humans; Immune Tolerance; Melanoma; Neoplasm Metastasis; Neoplasm Staging; Ski | 1986 |
[The immune status of patients with irradiated testicular neoplasms].
Topics: Adult; Dinitrochlorobenzene; Dysgerminoma; Humans; Immunity, Cellular; Male; Middle Aged; Neoplasm M | 1985 |